New #JITC article: Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial https://t.co/zQXH98vdAK @andreashr@GroupKyte
Vi ser etter en postdoc som er god på onkoimmunologisk maskinlæring.
Vi har gode resultater. https://t.co/tShPeHt4Cs
Vi vinner priser. https://t.co/3rUOBckQCQ
Vi er en fin gjeng. https://t.co/EvZJ8JSPIG
Stillingsannonse: https://t.co/0nZd9myAT3
Del gjerne!
We are delighted to share that the first results from the ALICE-trial were today published in Nature Medicine and presented at San Antonio Breast Cancer Symposium. Thanks to the patients and the study teams. Look forward to further work.
https://t.co/Ds12UlBNP6